Among the multiple vaccine safety systems that help monitor vaccine reactions, it’s a safe bet that many people will be looking at COVID-19 VAERS reports.
Unfortunately, some folks will be looking because they have had good luck misusing VAERS reports in the past.
COVID-19 VAERS Reports
Remember, just because something is reported to VAERS and is included in the VAERS database, that doesn’t automatically mean that a vaccine caused the reaction?
“Reports of all possible associations between vaccines and adverse events (possible side effects) are filed in VAERS. Therefore, VAERS collects data on any adverse event following vaccination, be it coincidental or truly caused by a vaccine. The report of an adverse event to VAERS is not documentation that a vaccine caused the event.”Guide to Interpreting VAERS Data
Still, these VAERS reports are very helpful, as experts look in them for patterns and signals that might indicate a true problem with a vaccine.
For example, it was using VAERS data that CDC and FDA vaccine experts quickly discovered that the older RotaShield rotavirus vaccine was associated with an increased risk of intussusception.
But again, you can read through VAERS reports and assume that they are all truly vaccine reactions.
So what’s in the COVID-19 VAERS reports so far?
Just what you would expect there to be…
“The majority of cases generally described appear to line up with what scientists and the vaccine makers have said are expected, potential side effects of Covid-19 vaccines.”Sharyl Attkisson
And that some have nothing to do with getting the COVID-19 vaccine!
Also note that each VAERS report can lead to multiple symptoms being entered into the system.
Of course, multiple VAERS reports for anaphylaxis are not unexpected considering the media reports of anaphylaxis.
It is also not unexpected that we would see some reports of deaths. Especially as these reports are after several million doses of vaccine have already been given during the COVID-19 vaccination campaign.
“CDC and FDA will continue to monitor for adverse events, including anaphylaxis, after receipt of COVID-19 vaccines and will regularly assess the benefits and risks of vaccination in the context of the evolving epidemiology of the pandemic. Continued monitoring in VAERS and additional monitoring in population-based surveillance systems, such as the CDC’s Vaccine Safety Datalink, will help to further characterize the risk for anaphylaxis after administration of COVID-19 vaccines.”Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine — United States, December 14–23, 2020
A vaccination campaign that is being closely monitored to make sure COVID-19 vaccines are indeed safe, with few risks and which has not found any unexpected side effects.
More on COVID-19 VAERS Reports
- Fainting After Getting a COVID-19 Vaccine
- Have Thousands Been Negatively Affected After Getting a COVID-19 Vaccine?
- Answering Your Concerns About the COVID-19 Vaccine Development Process
- COVID-19 Vaccine Safety Monitoring Systems
- Look Who’s Getting the COVID-19 Vaccine
- Countering COVID-19 Vaccine Hesitancy
- The Truth About COVID-19 Vaccines
- Underreporting of Side Effects to VAERS
- Did 79.4% of the Reported Child Deaths to VAERS Get a Vaccine on the Day They Died?
- Side Effects and Adverse Events Following Immunizations
- Vaccines and Sudden Unexplained Death in Children
- Is It a Vaccine Reaction?
- Guide to Interpreting VAERS Data
- Submitting a Report to VAERS
- VAERS Data
- MMWR – Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine — United States, December 14–23, 2020